NEW YORK, Sept. 16, 2016 -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Middle District of Tennessee on behalf of investors who purchased Quorum Health Corporation (NYSE:QHC) securities (1) pursuant and/or traceable to the Registration Statement issued in connection with the Company’s spinoff from Community Health Systems, Inc. effective on or about April 29, 2016; and/or (2) on the open market between May 2, 2016 and August 10, 2016.
Click here to learn about the case: http://www.wongesq.com/pslra/quorum-health-corporation. There is no cost or obligation to you.
The complaint alleges that during the Class Period, Quorum made false and/or misleading statements and/or failed to disclose that: (a) several of Quorum’s hospitals were under-performing at the time of the spinoff from Community Health Systems, Inc.; (b) there were numerous other signs of deficiency at the time of the spinoff; (c) Quorum omitted/and or failed to inform investors of the above-mentioned concerns; and (d) as a result, Quorum’s public statements were materially false and misleading at all relevant times.
On August 10, 2016, Quorum filed a Quarterly Report on Form 10-Q, decreasing its 2016 guidance revenues due to impairment charges, goodwill loss from divesting certain hospitals, and carryover allocation of goodwill at the time of the spinoff.
If you suffered a loss in Quorum you have until November 8, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra/quorum-health-corporation.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: [email protected]


Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Bank of America's $72.5M Epstein Settlement: What You Need to Know
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments
Chinese Universities with PLA Ties Found Purchasing Restricted U.S. AI Chips Through Super Micro Servers
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026 



